Home > Insider Trading > Filing (0000899243-19-017181)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1596946	Quotient Ltd	QTNT	In Vitro & In Vivo Diagnostic Substances (2835)	264719797

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1604877	Frederick Hallsworth	28 Esplanade St Helier Y9 JE2 3QA		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Acquisiton	2019-06-13	3,150	$8.70	3,150	No	4	P	Indirect	By wife

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By wife

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Ordinary Shares	74,398	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Ordinary Shares	Ordinary Share Option (Right to Buy)	$11.62		2025-10-31	7,505	7,505	Direct
Ordinary Shares	Ordinary Share Option (Right to Buy)	$8.00		2024-04-29	5,000	5,000	Direct
Ordinary Shares	Option to Purchase Ordinary Shares	$0.00	2014-02-13	2022-08-30	20,014	20,014	Direct
Ordinary Shares	Ordinary Share Option (Right to Buy)	$9.95		2024-10-31	5,025	5,025	Direct
Ordinary Shares	Ordinary Share Option (Right to Buy)	$5.73		2026-10-31	8,726	8,726	Direct
Ordinary Shares	Ordinary Share Option (Right to Buy)	$5.21		2027-10-31	9,597	9,597	Direct
Ordinary Shares	Restricted Stock Units	$0.00			2,879	2,879	Direct
Ordinary Shares	Restricted Stock Units	$0.00			9,360	9,360	Direct
Ordinary Shares	Ordinary Share Option (Right to Buy)	$6.41		2028-10-31	6,240	6,240	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2025-10-31	7,505	7,505	Direct
2024-04-29	5,000	5,000	Direct
2022-08-30	20,014	20,014	Direct
2024-10-31	5,025	5,025	Direct
2026-10-31	8,726	8,726	Direct
2027-10-31	9,597	9,597	Direct
	2,879	2,879	Direct
	9,360	9,360	Direct
2028-10-31	6,240	6,240	Direct

Footnotes

Restricted Stock Units convert into ordinary shares on a one-for-one basis.
All 7,505 options have vested and remain exercisable.
All 5,000 options have vested and remain exercisable.
The exercise price will be paid in pounds sterling, at GBP0.91 per share.
All 5,025 options have vested and remain exercisable.
5,818 options have vested on October 31, 2018 and remain exercisable, 2,908 options will vest on October 31, 2019.
3,199 options vested on October 31, 2018 and remain exercisable, 3,199 options will vest on October 31, 2019 and 3,199 options will vest on October 31, 2020.
On October 31, 2017, the Reporting Person was granted 5,758 restricted stock units, of which 2,879 have vested and have been exercised. The remaining 2,879 restricted stock units will vest on October 31, 2019.
On October 31, 2018, the Reporting Person was granted 18,721 restricted stock units, of which 9,361 have vested and have been exercised. The remaining 9,360 restricted stock units will vest in two equal installments on July 30, 2019 and October 31, 2019.
The options vest and become exercisable in three equal annual installments beginning October 31, 2019.